EMCI (Epic Medical Concepts & Innovations, Inc.) announced today that it has licensed new technology, the OroSTIFF, developed by Dr. Steven Barlow at the University of Kansas. EMCI plans to commercialize the technology and sell the product worldwide.
“The OroSTIFF represents yet another breakthrough from KU for patients suffering from degenerative diseases,” says Peter Lucas, COO of EMCI. “This technology will take much of the guesswork out of treatments.”